Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-652 in Osteoarthritis of the Knee
NCT01207115Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ABT-652 in knee osteoarthritis (OA), sponsored by AbbVie Inc.. Started Sep 2010; status: completed.
02
Drugs
ABT-652
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01207115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207115.